产品名称
Anti-YY1AP1 Antibody, from rabbit, purified by affinity chromatography
biological source
rabbit
conjugate
unconjugated
antibody form
affinity isolated antibody
antibody product type
primary antibodies
clone
polyclonal
purified by
affinity chromatography
species reactivity
mouse, human, rat
species reactivity (predicted by homology)
chimpanzee (based on 100% sequence homology)
technique(s)
immunohistochemistry: suitable
western blot: suitable
NCBI accession no.
UniProt accession no.
shipped in
wet ice
target post-translational modification
unmodified
Quality Level
Gene Information
human ... YY1AP1(55249)
Analysis Note
Evaluated by Western Blotting in A431 cell lysate.
Western Blotting Analysis: 0.5 µg/mL of this antibody detected YY1AP1 in 10 µg of A431 cell lysate.
Western Blotting Analysis: 0.5 µg/mL of this antibody detected YY1AP1 in 10 µg of A431 cell lysate.
Application
Research Category
Apoptosis & Cancer
Apoptosis & Cancer
Research Sub Category
Apoptosis - Additional
Apoptosis - Additional
This Anti-YY1AP1 antibody is validated for use in WB, IH for the detection of YY1AP1.
Western Blotting Analysis: 0.5 µg/mL from a representative lot detected YY1AP1 in 10 µg of C2C12, Hek293, HeLa, HepG2, human placenta, Huvec, Jurkat, L6, mouse brain, NIH-3T3, PC12, PC3, and Raw 264.7 lysate.
Immunohistochemistry Analysis: A 1:50-250 dilution from a representative lot detected YY1AP1 in human cerebellum, mouse hindbrain, and mouse cerebellum tissue.
Immunohistochemistry Analysis: A 1:50-250 dilution from a representative lot detected YY1AP1 in human cerebellum, mouse hindbrain, and mouse cerebellum tissue.
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
General description
YY1-associated protein 1 (YY1AP1), also known as Hepatocellular carcinoma susceptibility protein, Hepatocellular carcinoma-associated protein 2, is encoded by the gene name YY1AP1, HCCA2, and YY1AP. YY1AP1 has been demonstrated to enhance transcription activation by interacting with YY1. Recent studies have shown that YY1AP1 may play a role in cell cycle regulation. YY1AP1 interacts with YY1 and MAD2L2. YY1AP1 is expressed ubiquitously. YY1AP1 has been detected in small intestine, skeletal muscle, lung, pancreas, brain, stomach, spleen, colon and heart. At very low levels, YY1AP1 has been detected in healthy liver. YY1AP1 is highly expressed in most liver carcinomas.
~90 kDa observed. The endogenous YY1AP protein signal is found at 90 kDa, in agreement with the predicted protein size of 750 amino acids derived from open reading frame (Wang, C.Y., et al. (2004). J. Biol. Chem. 279:17750-17755).
Immunogen
Epitope: Near N-terminal
KLH-conjugated linear peptide corresponding to human YY1AP1 near the N-terminal.
Other Notes
Concentration: Please refer to lot specific datasheet.
Physical form
Affinity purified
Purified rabbit polyclonal in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide.
Preparation Note
Stable for 1 year at 2-8°C from date of receipt.
未找到合适的产品?
试试我们的产品选型工具.
存储类别
12 - Non Combustible Liquids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
Dong-Chuan Guo et al.
American journal of human genetics, 100(1), 21-30 (2016-12-13)
Fibromuscular dysplasia (FMD) is a heterogeneous group of non-atherosclerotic and non-inflammatory arterial diseases that primarily involves the renal and cerebrovascular arteries. Grange syndrome is an autosomal-recessive condition characterized by severe and early-onset vascular disease similar to FMD and variable penetrance
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持